Literature DB >> 7354064

Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins.

J L Goldstein, Y K Ho, M S Brown, T L Innerarity, R W Mahley.   

Abstract

The synthesis and accumulation of cholesteryl esters by monolayers of mouse peritoneal macrophages was stimulated 20- to 160-fold by incubation with beta-migrating very low density lipoproteins (beta-VLDL, density less than 1.006 g/ml) isolated from the plasma of cholesterol-fed dogs. Three other cholesterol-rich lipoprotein fractions obtained from the plasma of the same hypercholesterolemic dogs, including low density lipoprotein (LDL), cholesterol-induced high density lipoprotein (HDLc), and apo-E HDLc, had little to no stimulatory effect. Plasma VLDL (density less than 1.006 g/ml) from normal dogs did not increase cholesteryl ester formation in macrophages. The enhancement in cholesteryl ester synthesis and accumulation by hypercholesterolemic canine beta-VLDL was due to the presence of a high affinity binding site on the macrophage cell surface that mediated the uptake and lysosomal degradation of the beta-VLDL. Competition studies with fucoidin and dextran sulfate indicated that the receptor for canine beta-VLDL was different from that previously described for human acetylated low density lipoprotein (acetyl-LDL). Prior incubation of macrophage monolayers with either unlabeled canine beta-VLDL or human acetyl-LDL, both of which raised the cellular content of cholesteryl esters, reduced the ability of the cells to degrade 125I-labeled beta-VLDL, suggesting that the receptor for beta-VLDL is subject to regulation. The current findings indicate: 1) that macrophages possess a high affinity receptor that recognizes one of the four cholesterol-rich lipoproteins present in the plasma of cholesterol-fed dogs, beta-VLDL, and 2) that the receptor-mediated ingestion of beta-VLDL leads to cholesteryl ester deposition in these cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354064

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Lipoprotein degradation and cholesterol esterification in primary cell cultures of rabbit atherosclerotic lesions.

Authors:  O Jaakkola; T Nikkari
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

2.  Lipoprotein receptor activity of peritoneal macrophages from insulin-deficient mice.

Authors:  G Cheng; H X Wang; J M Zhang; Y X Zong; Z C Feng
Journal:  J Tongji Med Univ       Date:  1991

3.  Macrophages, extracellular matrix, and lipoproteins in arterial cholesterol balance.

Authors:  Germán Camejo; Eva Hurt-Camejo
Journal:  J Lipid Res       Date:  2013-11-19       Impact factor: 5.922

4.  Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?

Authors:  B H Chung; J P Segrest; K Smith; F M Griffin; C G Brouillette
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

5.  Lipoprotein lipase secretion by human monocytes and rabbit alveolar macrophages in culture.

Authors:  E M Mahoney; J C Khoo; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

6.  Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E.

Authors:  S K Basu; M S Brown; Y K Ho; R J Havel; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  Degradation of lipoproteins by human monocyte-derived macrophages. Evidence for two distinct processes for the degradation of abnormal very-low-density lipoprotein from subjects with type III hyperlipidaemia.

Authors:  A K Soutar; B L Knight
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

8.  [Lysosomal enzyme activity of monocytes/macrophages following incubation with postprandial hyperlipemic serum and its significance for the development of atherosclerosis].

Authors:  K Henze; G Wolfram
Journal:  Klin Wochenschr       Date:  1988-02-15

9.  The epidermal growth factor homology domain of the LDL receptor drives lipoprotein release through an allosteric mechanism involving H190, H562, and H586.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  J Biol Chem       Date:  2008-08-03       Impact factor: 5.157

10.  Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia.

Authors:  C B Blum; R J Deckelbaum; L D Witte; A R Tall; J Cornicelli
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.